Methods of monitoring conditions by sequence analysis
US10266901B2 · kind B2 · utility
9Cited by
159References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 4, 2016 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Feb 4, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
There is a need for improved methods for determining the diagnosis and prognosis of patients with conditions, including autoimmune disease and cancer. Provided herein are methods for using DNA sequencing to identify personalized biomarkers in patients with autoimmune disease and other conditions. Identified biomarkers can be used to determine the disease state for a subject with an autoimmune disease or other condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.